Invest in a Noor location · Coral Springs is open now
Don't invest in Noor. Invest in the location.
Noor Medical Group is a pharmacy developer — we build, license, staff, and launch each sterile compounding pharmacy as a discrete capital project. Right now that project is Coral Springs: a proposed $1.8M valuation before this round, backed by secured clinical relationships, validated research demand, and a clear 3–5 year strategic exit. Back this location while you still can.
Pre-Money Valuation
Supported by lease LOI, referral access, cleanroom pricing.
U.S. Infusion Market
Nearly 10% annual growth through 2034.
Facility Security
Signed lease LOI with expansion rights at 3080 NW 99th Ave.
Strategic Exit Horizon
Sale to a national infusion operator or IPO.
Why Coral Springs is uniquely positioned
Most startup pharmacies struggle with customer acquisition and regulatory delay. Noor begins Coral Springs with established clinical referral pipelines across Broward, Boca Raton, Wellington, and West Palm Beach — and a research center that explicitly requested our pharmacy on site.
Research Demand
A clinical research center explicitly requested our pharmacy on site — pre-launch demand for study protocol preparation.
Fixed-Price Cleanroom
Proposal locked with specialized engineers, eliminating construction cost-overrun risk for USP 797/800.
24-Month Downside Modeling
Stress-tested cash flow projections with conservative ramp-up and working capital contingencies.
Pharmacy Counsel Oversight
Dedicated health regulatory counsel reviewing every compounding, billing, and payer workflow.
Strategic exit scenarios (3–5 year horizon)
1. Strategic Acquisition. Preferred exit — acquisition by an established national infusion operator such as Option Care Health or KabaFusion, or a regional health system seeking accredited South Florida sterile compounding capacity.
2. Management Buyout / Redemption. Secondary alternative leveraging strong operational cash flow to redeem investor shares at an attractive multiple.
3. Multi-Site Expansion & IPO. Long-term ambition to replicate this model into top metro areas nationwide.
Key Leadership Hires
- Pharmacist in Charge (PIC): Sterile compounding & USP specialist candidate identified.
- Quality & Sterility Lead: Overseeing cleanroom SOPs, environmental testing, batch verification.
- Compounding Technicians: Experienced in aseptic technique and automated compounding devices.
- Specialty Billing Specialists: Dedicated prior-authorization and reimbursement team.
- Temperature-Controlled Couriers: Reliable home delivery throughout South Florida.
Coral Springs Flagship · Direct Executive Review
Request the Coral Springs investor memorandum & valuation deck.
Accredited investors and healthcare venture partners can request our full 24-month financial model, lease LOI documentation, and cleanroom engineering specs for the Coral Springs flagship.